Medicare Part D coverage · deflazacort · RxCUI 1870958
deflazacort 36 MG Oral Tablet
Per the CMS 2026 Part D formulary file, deflazacort 36 MG Oral Tablet is covered by 833 Medicare Part D plans (16.5% of enrollable products), averaging Tier 4.5, with prior authorization required on 96.2% of covering formularies.
- 16.5%
- Plan coverage
- 833
- Plans covering
- T4.5
- Avg tier
- 96.2%
- Prior auth required
What the CMS Formulary Data Shows for deflazacort 36 MG Oral Tablet
Per the CMS 2026 Part D formulary file, deflazacort 36 MG Oral Tablet (RxNorm concept RXCUI 1870958, generic name deflazacort) appears on 26 distinct formulary files spanning 833 Medicare Part D plan offerings - 16.5% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 5, with a cross-plan average of Tier 4.5.
Real-world access to deflazacort 36 MG Oral Tablet depends on utilization management as much as tier placement: 96.2% of covering formularies require prior authorization. 0% require step therapy. 15.4% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 99 Part D beneficiaries filled deflazacort 36 MG Oral Tablet in 2023, with total plan-and-beneficiary spending of $15,369,330 and an average per-beneficiary annual cost of $155,245.76. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry deflazacort 36 MG Oral Tablet today.
Coverage Details
- Formularies covering
- 26
- Plans covering
- 833
- Coverage rate
- 16.5%
- Tier range
- Tier 1 – Tier 5
- Average tier
- Tier 5, Specialty
Restrictions
- Prior authorization required
- 96.2% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 15.4% of formularies
2023 Medicare Spending
- Beneficiaries
- 99
- Total spending
- $15,369,330
- Avg per beneficiary
- $155,245.76
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering deflazacort 36 MG Oral Tablet
100 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| CalOptima Health OneCare Complete (HMO D-SNP) | Orange County Health Authority | T1 | Yes | $0 | CA |
| Mass General Brigham SCO (HMO D-SNP) | Mass General Brigham Health Plan, Inc | T1 | Yes | $0 | MA |
| Mass General Brigham One Care (HMO D-SNP) | Mass General Brigham Health Plan, Inc | T1 | Yes | $0 | MA |
| UHC Dual Complete IA-S001 (HMO-POS D-SNP) | Unitedhealthcare OF Wisconsin, Inc. | T5 | Yes | $0 | IA |
| UHC Dual Complete MO-S001 (HMO-POS D-SNP) | Unitedhealthcare OF Wisconsin, Inc. | T5 | Yes | $0 | MO |
| UHC Dual Complete NE-S001 (HMO-POS D-SNP) | Unitedhealthcare OF Wisconsin, Inc. | T5 | Yes | $0 | NE |
| UHC Dual Complete KS-S001 (HMO-POS D-SNP) | Unitedhealthcare OF Wisconsin, Inc. | T5 | Yes | $0 | KS |
| UHC Dual Complete MO-S3 (HMO-POS D-SNP) | Unitedhealthcare OF Wisconsin, Inc. | T5 | Yes | $0 | MO |
| UHC Dual Complete KS-Q1 (HMO-POS D-SNP) | Unitedhealthcare OF Wisconsin, Inc. | T5 | Yes | $0 | KS |
| UHC Dual Complete TN-S001 (HMO-POS D-SNP) | Unitedhealthcare Plan OF THE River Valley, Inc. | T5 | Yes | $0 | TN |
| UHC Dual Complete TN-Y001 (HMO-POS D-SNP) | Unitedhealthcare Plan OF THE River Valley, Inc. | T5 | Yes | $0 | TN |
| UHC Dual Complete TN-Y2 (HMO-POS D-SNP) | Unitedhealthcare Plan OF THE River Valley, Inc. | T5 | Yes | $0 | TN |
| AARP Medicare Advantage from UHC MI-0001 (PPO) | Unitedhealthcare Insurance Company | T5 | Yes | $0 | MI |
| UHC Dual Complete NM-Y1 (PPO D-SNP) | Unitedhealthcare Insurance Company | T5 | Yes | $0 | NM |
| UHC Dual Complete NM-S1 (PPO D-SNP) | Unitedhealthcare Insurance Company | T5 | Yes | $0 | NM |
| UHC Dual Complete NM-V1 (PPO D-SNP) | Unitedhealthcare Insurance Company | T5 | Yes | $0 | NM |
| UHC Dual Complete AZ-S001 (HMO-POS D-SNP) | Arizona Physicians IPA, Inc. | T5 | Yes | $0 | AZ |
| UHC Dual Complete AZ-Y001 (HMO-POS D-SNP) | Arizona Physicians IPA, Inc. | T5 | Yes | $0 | AZ |
| UHC Dual Complete VA-Y4 (PPO D-SNP) | Care Improvement Plus South Central Insurance Co. | T5 | Yes | $0 | VA |
| AARP Medicare Advantage from UHC AL-0001 (HMO-POS) | Unitedhealthcare OF THE Midlands, Inc. | T5 | Yes | $0 | AL |
Show the next 30 plans
Showing top 50 of 100 plans.
Frequently Asked Questions
Is deflazacort 36 MG Oral Tablet covered by Medicare Part D?
Yes, deflazacort 36 MG Oral Tablet is covered by 833 Medicare Part D plans (16.5% of all Part D formularies).
What tier is deflazacort 36 MG Oral Tablet on Medicare Part D plans?
deflazacort 36 MG Oral Tablet averages Tier 4.5 across Part D plans, ranging from Tier 1 to Tier 5.
Does deflazacort 36 MG Oral Tablet require prior authorization?
96.2% of Part D formularies require prior authorization for deflazacort 36 MG Oral Tablet. Step therapy: 0%. Quantity limits: 15.4%.
How much does Medicare spend on deflazacort 36 MG Oral Tablet?
In 2023, total Medicare Part D spending on deflazacort 36 MG Oral Tablet was $15,369,330, covering 99 beneficiaries. The average spend per beneficiary was $155,245.76.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
- risperidone 37.5 MG Injection [Risperdal] T4.5
- efinaconazole 100 MG/ML Topical Solution [Jublia] T4.5
- letermovir 20 MG Oral Pellet [Prevymis] T4.5
- tedizolid phosphate 200 MG Injection [Sivextro] T4.5
- 0.5 ML tbo-filgrastim 0.6 MG/ML Prefilled Syringe [Granix] T4.5
- 0.8 ML tbo-filgrastim 0.6 MG/ML Prefilled Syringe [Granix] T4.5
Similar prior-authorization rate
- solriamfetol 75 MG Oral Tablet [Sunosi] 96.2% PA
- droxidopa 100 MG Oral Capsule 96.2% PA
- droxidopa 300 MG Oral Capsule 96.2% PA
- dasatinib 100 MG Oral Tablet [Phyrago] 96.2% PA
- tolvaptan 15 MG Oral Tablet 96.3% PA
- sapropterin dihydrochloride 500 MG Powder for Oral Solution [Zelvysia] 96.1% PA